HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model.

AbstractBACKGROUND:
Trauma-induced shock is associated with endothelial dysfunction. We examined whether the tyrosine kinase inhibitor bosutinib as an adjunct therapy to a balanced blood component resuscitation strategy reduces trauma-induced endothelial permeability, thereby improving shock reversal and limiting transfusion requirements and organ failure in a rat polytrauma transfusion model.
METHODS:
Male Sprague-Dawley rats (n=13 per group) were traumatised and exsanguinated until a MAP of 40 mm Hg was reached, then randomised to two groups: red blood cells, plasma and platelets in a 1:1:1 ratio with either bosutinib or vehicle. Controls were randomised to sham (median laparotomy, no trauma) with bosutinib or vehicle. Organs were harvested for histology and wet/dry (W/D) weight ratio.
RESULTS:
Traumatic injury resulted in shock, with higher lactate levels compared with controls. In trauma-induced shock, the resuscitation volume needed to obtain a MAP of 60 mm Hg was lower in bosutinib-treated animals (2.8 [2.7-3.2] ml kg-1) compared with vehicle (6.1 [5.1-7.2] ml kg-1, P<0.001). Lactate levels in the bosutinib group were 2.9 [1.7-4.8] mM compared with 6.2 [3.1-14.1] mM in the vehicle group (P=0.06). Bosutinib compared with vehicle reduced lung vascular leakage (W/D ratio of 5.1 [4.6-5.3] vs 5.7 [5.4-6.0] (P=0.046) and lung injury scores (P=0.027).
CONCLUSIONS:
Bosutinib as an adjunct therapy to a balanced transfusion strategy reduced resuscitation volume, improved shock reversal, and reduced vascular leak and organ injury in a rat polytrauma model.
AuthorsDerek J B Kleinveld, Liza Botros, M Adrie W Maas, Jesper Kers, Jurjan Aman, Markus W Hollmann, Nicole P Juffermans
JournalBritish journal of anaesthesia (Br J Anaesth) Vol. 126 Issue 5 Pg. 958-966 (May 2021) ISSN: 1471-6771 [Electronic] England
PMID33685634 (Publication Type: Journal Article)
CopyrightCopyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Aniline Compounds
  • Nitriles
  • Protein Kinase Inhibitors
  • Quinolines
  • Lactic Acid
  • bosutinib
Topics
  • Aniline Compounds (pharmacology)
  • Animals
  • Blood Transfusion (methods)
  • Disease Models, Animal
  • Endothelium, Vascular (metabolism, pathology)
  • Lactic Acid (metabolism)
  • Lung Injury (drug therapy, etiology)
  • Male
  • Multiple Trauma (complications, drug therapy, physiopathology)
  • Nitriles (pharmacology)
  • Permeability (drug effects)
  • Protein Kinase Inhibitors (pharmacology)
  • Quinolines (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Resuscitation (methods)
  • Shock (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: